Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2314391
Max Phase: Preclinical
Molecular Formula: C17H24N2O
Molecular Weight: 272.39
Molecule Type: Small molecule
Associated Items:
ID: ALA2314391
Max Phase: Preclinical
Molecular Formula: C17H24N2O
Molecular Weight: 272.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)CCCCOc1cccc2cccnc12
Standard InChI: InChI=1S/C17H24N2O/c1-3-19(4-2)13-5-6-14-20-16-11-7-9-15-10-8-12-18-17(15)16/h7-12H,3-6,13-14H2,1-2H3
Standard InChI Key: OZBWZIJCYMGEAI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 272.39 | Molecular Weight (Monoisotopic): 272.1889 | AlogP: 3.74 | #Rotatable Bonds: 8 |
Polar Surface Area: 25.36 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.32 | CX LogP: 3.28 | CX LogD: 0.46 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.68 | Np Likeness Score: -1.25 |
1. Vandekerckhove S, Müller C, Vogt D, Lategan C, Smith PJ, Chibale K, De Kimpe N, D'hooghe M.. (2013) Synthesis and antiplasmodial evaluation of novel (4-aminobutyloxy)quinolines., 23 (1): [PMID:23195733] [10.1016/j.bmcl.2012.10.094] |
2. Vandekerckhove S, Tran HG, Desmet T, D'hooghe M.. (2013) Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents., 23 (16): [PMID:23838261] [10.1016/j.bmcl.2013.06.014] |
Source(1):